PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2011

Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.

Rat / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 21840572 ↗2011Reported benefit

Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.

RatWoundWistarMaleIntravenous, intraperitoneal or intragastric10 ug/kg or 10 ng/kgImmediately after challenge

Model: Tail/limb amputation with heparin, warfarin or aspirin

BPC 157 reduced bleeding time and thrombocytopenia and prolonged survival after amputation in anticoagulant-treated rats.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.